| Completed | A Study to Assess the Engagement and Usefulness of Care4Today Digital Platform for Disease Management in Coron Coronary Artery Disease (CAD), Peripheral Artery Disease (PAD) | — | 2023-11-29 |
| Completed | A Study of JNJ-68284528 Out-of-Specification (OOS) for Commercial Release in Participants With Multiple Myelom Multiple Myeloma | Phase 2 | 2022-05-13 |
| Recruiting | A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease Crohn Disease, Colitis, Ulcerative | — | 2021-06-24 |
| Completed | A Study of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Evaluated as a Fixed Dose Comb HIV-1 | Phase 4 | 2020-07-01 |
| Completed | A Study to Investigate if Early Atrial Fibrillation (AF) Diagnosis Reduces Risk of Events Like Stroke in the R Atrial Fibrillation | — | 2020-02-25 |
| Completed | Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year Crohn Disease | Phase 3 | 2018-03-29 |
| Terminated | A Study to Quantify Use of Anticoagulation to Improve Management of Atrial Fibrillation Atrial Fibrillation | — | 2017-12-29 |
| Completed | A Study to Evaluate the Efficacy and Safety of (D/C/F/TAF) Once Daily Fixed Dose Combination (FDC) Regimen in HIV-1 | Phase 3 | 2017-07-31 |
| Terminated | Multiple Myeloma Patient Registry Multiple Myeloma | — | 2017-05-08 |
| Completed | A Study to Assess the Validation and Mapping of the Suicide Ideation and Behavior Assessment Suicidality | — | 2017-03-31 |
| Completed | Sustainable Early Episode Clinic Study (SEEC) Schizophrenia, Schizoaffective Disorder | N/A | 2017-01-31 |
| Completed | Smartphones to Improve Rivaroxaban ADHEREnce in Atrial Fibrillation Atrial Fibrillation | Phase 4 | 2016-12-21 |
| Completed | Study to Evaluate the Relative Bioavailability of Fixed-dose Combination Tablet Darunavir/Cobicistat/Emtricita Healthy | Phase 1 | 2016-12-01 |
| Completed | A Study to Evaluate Dara-CyBorD in Previously Untreated and Relapsed Subjects With Multiple Myeloma Multiple Myeloma | Phase 2 | 2016-11-09 |
| Terminated | An Efficacy and Safety Study of Infliximab Dose Escalation in Pediatric Participants With Inflammatory Bowel D Inflammatory Bowel Diseases | Phase 4 | 2016-04-01 |
| Completed | Comparative and Pragmatic Study of Golimumab Intravenous (IV) (Simponi Aria) Versus Infliximab (Remicade) in R Arthritis, Rheumatoid | — | 2016-02-25 |
| Completed | Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability Prostate Cancer | — | 2015-12-01 |
| Completed | A Study of Rivaroxaban for Early Discharge of Low Risk Pulmonary Embolism From the Emergency Department Pulmonary Embolism | Phase 4 | 2015-10-15 |
| Completed | A Study to Assess the Independent Effects of 4-Factor Prothrombin Complex Concentrate and Tranexamic Acid on B Healthy | Phase 1 | 2015-08-27 |
| Completed | Family Intervention in Recent Onset Schizophrenia Treatment (FIRST) Schizophrenia | — | 2015-07-24 |
| Completed | A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-A Schizophrenia, Psychotic Disorders | Phase 3 | 2015-07-08 |
| Completed | Study to Evaluate the Effects of Tramadol Hydrochloride on Cardiac Repolarization in Healthy Participants Healthy | Phase 1 | 2014-12-04 |
| Completed | An Efficacy and Safety Study of Simeprevir and Sofosbuvir With and Without Ribavirin in Participants With Recu Hepatitits C | Phase 2 | 2014-08-01 |
| Completed | A Study to Examine Patient Characteristics, Health Care Management and Health Outcomes of Hepatitis C Virus (H Hepatitis C Virus | — | 2014-02-01 |
| Completed | Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertensio Diabetes Mellitus, Type 2, Hypertension | Phase 4 | 2013-10-01 |
| Completed | A Dose Ranging Escalation Study of Tramadol Hydrochloride in Healthy Volunteers Healthy | Phase 1 | 2013-08-01 |
| Completed | A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonis Atrial Fibrillation, Percutaneous Coronary Intervention | Phase 3 | 2013-05-10 |
| Completed | A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease Hepatosplenic T-Cell Lymphoma | Phase 4 | 2013-03-21 |
| Completed | Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II) Atrial Fibrillation | — | 2013-02-20 |
| Completed | A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Atrial Fibrillation | Phase 3 | 2013-02-01 |
| Withdrawn | An Open-label Evaluation of Tapentadol Extended Release (ER) in Participants With Moderate to Severe Chronic P Pain, Chronic Back Pain, Chronic Low Back Pain | Phase 4 | 2012-08-01 |
| Completed | Velcade (Bortezomib) Consolidation After Transplant Multiple Myeloma | Phase 3 | 2012-01-13 |
| Completed | Pharmacokinetics Study of Oral Rivaroxaban in Healthy Participants Pharmacokinetics, Bioavailability, Healthy Participants | Phase 1 | 2011-10-01 |
| Completed | A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Sch Schizoaffective Disorder | Phase 3 | 2010-09-01 |
| Completed | Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations Schizophrenia, Bipolar Disorder | — | 2010-08-01 |
| Completed | Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Atrial Fibrillation | — | 2010-06-01 |
| Completed | 15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated Schizophrenia | Phase 4 | 2010-05-01 |
| Completed | A Single-arm, Open-label, Study to Assess the Pharmacokinetics of Darunavir and Ritonavir, Darunavir and Cobic HIV, HIV Infections, Pregnancy | Phase 3 | 2009-04-09 |
| Active Not Recruiting | Psoriasis Longitudinal Assessment and Registry Psoriasis | — | 2007-06-21 |
| Approved For Marketing | Expanded Access Program (EAP) for Participants With Advanced Cancers and Fibroblast Growth Factor Receptor (FG Advanced Cancers and FGFR Genetic Alterations | — | — |
| Available | Expanded Access Program (EAP) for Ciltacabtagene Autoleucel (Cilta-Cel) Out-of-Specification (OOS) in Particip Multiple Myeloma | — | — |